Overview

Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)

Status:
Not yet recruiting

Trial end date:
2022-07-01

Target enrollment:

Participant gender:

Summary

Phase III, single-center, randomized, double-blind, parallel, placebo-controlled clinical study

Phase:

Phase 3

Details

Lead Sponsor:

HRH Holdngs Limited
HRH Pharmaceuticals Limited

Collaborators:

Clinical Research Unit / High Complexity Center (CRU/HCC) / Galzu Institute
GALZU INSTITUTE OF RESEARCH, TEACHING, APPLIED SCIENCE AND TECHNOLOGY, Brazil
GALZU INSTITUTE OF RESEARCH, TEACHING, SCIENCE AND APPLIED TECHNOLOGY, Brazil
SANTA CASA DE MISERICORDIA DE CAMPOS HOSPITAL (SCMCH), Brazil
UNIVERSIDADE ESTADUAL DO NORTE FLUMINENSE (UENF), Brazil